Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S.…
<!-- Name:DistributionId Value:8777866 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
submission
AtlasClear, Inc. and Quantum FinTech Acquisition Corporation Announce Confidential…
<!-- Name:DistributionId Value:8750440 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Wrestlers make written submission before oversight panel
Express News Service
NAGPUR: Country’s top wrestlers including Olympic medallists Bajrang Punia and Sakshi Malik and multiple World Championships medallist Vinesh…
XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to…
<!-- Name:DistributionId Value:8740469 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
InvestmentPitch Media Video Discusses FSD Pharma’s Submission of its Clinical Trial…
VANCOUVER, British Columbia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of…
Poland’s Oscar submission, ‘EO,’ looks to ease the plight of…
When acclaimed Polish director Jerzy Skolimowski and his wife and collaborator, screenwriter and producer Ewa Piaskowska, set out to create a “donkey’s road movie,” they wanted their project…
SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for…
STAMFORD, Conn., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines…
CI Financial Confirms Confidential Submission of Draft Registration Statement for…
Article content TORONTO & MIAMI — CI Financial Corp. (TSX: CIX; NYSE: CIXX) (“CI”), the parent of CI US Holdings Inc. (“CI US”), confirms that CI US has confidentially submitted a draft…
Revive Therapeutics Announces Submission of Type C Meeting Request to FDA for Amended…
TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the…
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access…
CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac…